Literature DB >> 11678453

Geographical variation in mortality from systemic lupus erythematosus in the United States.

S J Walsh1, L M DeChello.   

Abstract

The aim was to identify demographic and environmental factors that affect the incidence and course of systemic lupus erythematosus (SLE) by studying geographical variation in mortality from the disease. Counts of SLE deaths during a 10-y period were determined for each of the 3111 counties in the United States. The counts were subjected to statistical techniques for detecting spatial clusters with significantly higher or lower mortality than expected. Census data were used to compare attributes of the resulting clusters. Four clusters with significantly elevated SLE mortality were identified. They were centered in Alabama, Arkansas, Louisiana and New Mexico and had 41-65% more SLE deaths than expected. Four other clusters with significantly low mortality were centered in Minnesota, Vermont, Virginia and Washington and had 32-44% fewer deaths than expected. Comparison of SLE mortality rates between the New Mexico and Vermont clusters yielded relative risks of 3.2, 3.4 and 5.9 for white, black and other race women, respectively, and of 2.1, 5.2 and 'undefined' for white, black and other race men. Census data showed that the clusters with elevated mortality had higher poverty rates and/or greater concentrations of ethnic Hispanics than those with lower mortality. SLE mortality rates show great regional variation within the United States. The variation appears to reflect, in part, geographical patterns in socioeconomic status and in the distribution of persons of Hispanic origin.

Entities:  

Mesh:

Year:  2001        PMID: 11678453     DOI: 10.1191/096120301682430230

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  22 in total

Review 1.  Ethnic disparities in patients with systemic lupus erythematosus.

Authors:  América G Uribe; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups.

Authors:  Sergio Durán; Mandar Apte; Graciela S Alarcón
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

Review 3.  From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.

Authors:  Alan G Baxter; Margaret A Jordan
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 4.  A Review and Framework for Categorizing Current Research and Development in Health Related Geographical Information Systems (GIS) Studies.

Authors:  A K Lyseen; C Nøhr; E M Sørensen; O Gudes; E M Geraghty; N T Shaw; C Bivona-Tellez
Journal:  Yearb Med Inform       Date:  2014-08-15

Review 5.  [Changes in mortality and morbidity in systemic lupus erythematosus].

Authors:  G Chehab; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

Review 6.  Neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  David Hermosillo-Romo; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico.

Authors:  América G Uribe; Juanita Romero-Díaz; Mandar Apte; Mónica Fernández; Paula I Burgos; John D Reveille; Jorge Sánchez-Guerrero; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-08-28       Impact factor: 7.580

8.  Intravenous cyclophosphamide--resistant systemic lupus erythematosus in Arizona.

Authors:  Mehul P Dixit; Erika Bracamonte; Naznin Dixit
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

9.  Geographical Clustering of Juvenile Onset Systemic Lupus Erythematosus within the Sultanate of Oman.

Authors:  Reem Abdwani; Safiya Al-Abrawi; Sharef Waadallah Sharef; Ibrahim Al-Zakwani
Journal:  Oman Med J       Date:  2013-05

Review 10.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.